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Abstract
Introduction Sedation and analgesia are provided by using different agents and techniques in different
countries. The goal is to achieve early spontaneous breathing and to obtain an awake and cooperative
pain-free patient. It was the aim of this study to conduct a survey of the agents and techniques used
for analgesia and sedation in intensive care units in Germany.
Methods A survey was sent by mail to 261 hospitals in Germany. The anesthesiologists running the
intensive care unit were asked to fill in the structured questionnaire about their use of sedation and
analgesia.
Results A total of 220 (84%) questionnaires were completed and returned. The RAMSAY sedation
scale was used in 8% of the hospitals. A written policy was available in 21% of hospitals. For short-
term sedation in most hospitals, propofol was used in combination with sufentanil or fentanyl. For long-
term sedation, midazolam/fentanyl was preferred. Clonidine was a common part of up to two-thirds of
the regimens. Epidural analgesia was used in up to 68%. Neuromuscular blocking agents were no
longer used.
Conclusion In contrast to the US 'Clinical practice guidelines for the sustained use of sedatives and
analgesics in the critically ill adult', our survey showed that in Germany different agents, and frequently
neuroaxial techniques, were used.
Introduction
Critical care therapies such as ventilation, invasive procedures
or other measures inducing pain or stress require analgesia
and sedation of the patient. Adequate analgesia and sedation
is supposed to prevent stress-induced reactions such as
hypermetabolism, sodium and water retention, hypertension,
tachycardia and altered wound healing [1-3] and to optimize
patient comfort. Whipple and colleagues [4] pointed out that
70% of the patients in an intensive care unit (ICU) indicate
pain as the worst recollection, although 70–90% of the nurses
and physicians taking care of them claimed their patients to be
pain free. If sedation is too deep it can have negative side
effects [5-7] such as increased risk of pneumonia, venous
thrombosis, bowel motility problems, hypotension and a pro-
longed stay in the ICU, resulting in increased costs [8-10]. The
requirements for ideal analgesia and sedation are the ability to
sedate the patient deeply for necessary procedures, but with
medication of short duration so that the patient can be quickly
responsive and cooperative [11].
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Goal-oriented sedation [5,6,12,13] complies with the estab-
lishment of a modern ventilation regimen to allow early sponta-
neous breathing [14]. This is shown in the use of short-acting
agents for analgesia and sedation, as was demonstrated in
surveys from the UK [15] and Denmark [16].
Soliman and colleagues [17] conducted a survey in 16 Euro-
pean countries about the current practice of sedation. They
found distinct differences between countries in the practice of
analgesia and sedation: 75% of ventilated patients in the UK
received medication for analgesia and sedation continuously,
whereas only 30% of Italian ventilated patients did so. The
most commonly used medication for continuous sedation in
Europe is propofol and midazolam, whereas in the USA [18]
midazolam and propofol is administered as the preferred med-
ication for short-term sedation and lorazepam for long-term
sedation. Analgesic agents differ broadly between countries,
and neuroaxial techniques are not often reported [15-18].
The goal of the present survey was to ask for the current prac-
tice of analgesia and sedation in German ICUs.
Methods
Data collection
From an address database of the German Society for
Anesthesiology and Intensive Care Medicine (Deutsche Ges-
ellschaft für Anästhesiologie und Intensivmedizin [DGAI]) with
a total of 808 addresses of ICUs (45 university hospitals and
763 general hospitals) a simple random sample of one-third of
the addresses (254 general hospitals and 15 university ICUs)
were selected and written to. For eight hospitals the letter was
undeliverable. It was written up to four times to the hospitals
during May 2002 to October 2002. The return rate was 84%
(220 of 261). All data were included in the analysis. At this
return rate the 'non-responder bias' can be neglected [19].
The hospitals included in the analysis were 206 general hos-
pitals and 14 university hospitals. Numbers of hospital beds
varied between less than 300 beds in 71 hospitals, 300–499
in 88 hospitals, 500–1000 in 43 hospitals, and more than
1000 beds in 14 hospitals; 2 hospitals did not answer. The
questionnaire itself is provided in Additional file 1.
Duration of sedation
The periods of sedation were clustered in accordance with the
American guidelines [18] into the following groups: duration of
sedation less than 24 hours, 24–72 hours and more than 72
hours. In addition we asked about the duration of sedation dur-
ing weaning from ventilation.
Statistics
The data were collected in a Microsoft Access 97 database
and analyzed with the programs Microsoft Excel 9.0 and
SPSS for Windows (SPSS Inc., version 10.07). Univariate sta-
tistitical analyses were calculated depending on the scaling of
the data with the Mann–Whitney U-test or the χ2 test. If multi-
ple tests in multigroup comparison were necessary, we used
the Bonferroni–Holm sequential rejective multiple test proce-
dure [20].
Significant two-sided differences were defined as P < 0.05.
Results
General data
General hospitals were equipped with a median of 9 intensive
care beds (university hospitals 14), the median number of
patients in the ICU was 930 (university hospitals 1481) and
the resulting median nursing care days per year were 2565
(university hospitals 4950).
Procedure instructions for analgesia and sedation
Oral procedure instructions (departmental common consen-
sus) existed in 43% of the hospitals.
A standard operating procedure set out in writing existed in
21% of the hospitals.
Use of sedation scales
Sedation monitoring was done by 30% of the hospitals. It was
noticeable that only 8% of the hospitals provided data for the
question about which sedation scale was used. The Ramsay
scale [21] was named exclusively as the sedation scale used.
Medication costs
Sixty-two percent of all hospitals answered 'yes' when asked
about considering costs in their choice of medication. The
analysis showed that there were no significant differences in
the choice of agents compared with the hospitals that said 'no'
to this question (P = 0.758).
Choice of agents depending on the duration of 
sedation
Ninety-two percent of the hospitals stated that they selected
the medication depending on the expected duration of analge-
sia and sedation.
Day–night rhythm
Eighty-one percent of the hospitals tried to maintain a day–
night rhythm in their patients.
Neuromuscular blockade
Neuromuscular blockade no longer had a role in ICUs run by
anesthesiologists.
Withdrawal/transitional syndrome
Questioned about the frequency of withdrawal/transitional
syndrome, the hospitals stated an average rate of 20%.
Sedative agents
For sedation up to 24 hours, propofol was used significantly
more often (81%) as a continuous agent than midazolamAvailable online http://ccforum.com/content/9/2/R117
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(45%, P < 0.05). For sedation between 24 and 72 hours,
midazolam was used significantly more often (77%) than pro-
pofol (56%). For sedation longer than 72 hours, all hospitals
preferred midazolam (90%) as a sedative and only 25% of the
hospitals were using propofol. During weaning, 92% of the
hospitals used propofol for sedation, and 34% used
midazolam.
Analgesic agents
For analgesia up to 24 hours, sufentanil (35%) and fentanyl
(40%) were used most often. There was no significant differ-
ence in the use of these two agents. Thirty-eight percent of the
hospitals saw an indication for the use of piritramid, non-ster-
oidal anti-inflammatory drugs (NSAIDs) were used by 27%,
morphine was used by 9%, alfentanil by 2%, remifentanil by
6%, and hydromorphone was not an option in our question-
naire. It was not possible to derive from the data how often opi-
oids and NSAIDs were used as additional agents for analgesia
or as alternative drugs. For analgesic agents between 24 and
72 hours, fentanyl (55%) and sufentanil (53%) were used by
most of the hospitals. Morphine was used by 5%, piritramid by
16%, alfentanil by 2% and remifentanil by 2%. Twelve percent
of the hospitals saw an indication for the use of NSAIDs. For
analgesia of more than 72 hours, fentanyl was used in 64% of
hospitals, significantly more often than sufentanil (44%) was
used. The use of piritramid occurred in 9% of all hospitals,
morphine was used by 7%, alfentanil by 1% and remifentanil
by 1%. Ten percent of all hospitals were using NSAIDs. For
analgesia during weaning from ventilation, 39% of the hospi-
tals used fentanyl and 42% used sufentanil. No significant dif-
ference was shown between the usage of these two agents.
In all hospitals piritramid was used by 25%, morphine by 9%,
alfentanil by 2%, remifentanil by 6% and NSAIDs by 14% in
this phase.
Adjuvant techniques for analgesia and sedation
Clonidine was used by 35% of the hospitals for sedation of
less than 24 hours; 7% of the respondent hospitals decided
on ketamine (S). Haloperidol was not a selectable option in our
questionnaire. For sedation between 24 and 72 hours, cloni-
dine was used in 48% of the hospitals, and ketamine (S) by
20%. For sedation longer than 72 hours, clonidine was used
Table 1
Comparison of the used agents and techniques for analgesia and sedation
Agent/technique Percentage (95% confidence interval)
< 24 h 24–72 h >72 h Weaning
Midazolam 45.9 (36.1–55.6) 77.3 (71.0–83.6) 90.5 (86.4–94.5) 34.1 (23.4–44.8)
Diazepam 0.0 2.7 (- 10.3–15.8) 3.2 (- 9.8–16.2) 2.3 (- 10.8–15.3)
Propofol 81.4 (75.7–87.1) 55.9 (47.2–64.7) 26.4 (15.0–37.7) 72.3 (65.3–79.3)
Methohexital 1.4 (- 11.8–14.5) 2.7 (- 10.3–15.8) 4.1 (- 8.9–17.0) 2.3 (- 10.8–15.3)
GHBA 4.5 (8.4–17.5) 7.7 (- 5.0–20.4) 10.9 (- 1.5–23.4) 9.6 (- 3.0–22.1)
Remifentanil 5.9 (- 6.9–18.7) 2.3 (- 10.8–15.3) 1.4 (- 11.8–14.5) 5.9 (- 6.9–18.7)
Alfentanil 1.8 (- 11.3–14.9) 2.3 (- 10.8–15.3) 0.9 (- 12.3–14.1) 1.8 (- 11.3–14.9)
Fentanyl 40.0 (29.8–50.3) 55.9 (47.1–64.7) 65.0 (57.2–72.8) 30.0 (19.0–41.0)
Sufentanil 35.0 (24.4–45.7) 47.7 (38.2–57.3) 43.6 (33.7–53.5) 41.8 (31.8–51.9)
Piritramid 38.2 (27.8–48.6) 15.5 (3.3–27.6) 9.1 (- 3.5–21.7) 25.5 (14.1–36.9)
Morphine 8.6 (- 4.0–21.3) 4.5 (- 8.4–17.5) 7.3 (- 5.5–20.0) 8.6 (- 4.0–21.3)
PCA 25.5 (14.0–36.9) 15.5 (3.3–27.6) 9.5 (- 3.0–22.1) 12.3 (- 0.1–24.7)
Ketamine (S) 6.8 (- 5.9–19.6) 20.0 (8.2–31.8) 19.1 (13.6–36.4) 5.0 (- 7.9–17.9)
Clonidine 35.9 (25.3–46.5) 48.2 (38.7–57.7) 56.4 (47.7–65.1) 62.7 (54.6–70.8)
NSAIDs 26.8 (15.6–38.2) 13.2 (0.8–25.5) 10.5 (- 2.1–23.0) 14.1 (1.8–26.3)
NMBAs 3.6 (- 9.3–16.6) 0.0 0.0 0.0
PNB 15.5 (3.3–27.6) 12.7 (0.4–25.1) 10.0 (- 2.5–22.5) 7.7 (- 5.0–20.4)
PCEA 7.3 (- 5.5–20.0) 5.9 (- 6.9–18.7) 4.1 (- 8.9–17.0) 4.6 (- 8.4–17.5)
Epidural 68.2 (60.8–75.7) 59.1 (50.7–67.6) 45.9 (36.2–55.6) 42.3 (32.2–52.3)
GHBA, γ-hydroxybutyric acid; NMBAs, neuromuscular blocking agents; NSAIDs, non-steroidal anti-inflammatory drugs; PCA, patient-controlled 
analgesia; PCEA, patient-controlled epidural analgesia; PNB, peripheral nerve block.Critical Care    April 2005  Vol 9 No 2    Martin et al.
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by 56% of all the hospitals, and 19% were using ketamine (S).
During weaning from ventilation, the α2 agonist clonidine was
used by 62% of all hospitals, and 5% used ketamine (S) in this
phase.
Regional anesthetic techniques
A central neuroaxial block with an epidural catheter was used
by 68% of all hospitals as a routine for analgesia up to 24
hours. Peripheral blocks were used by 15% of all hospitals. As
a regional anesthetic technique for analgesia between 24 and
72 hours, epidural analgesia was used by 60% of all hospitals,
and peripheral blocks were used by 13%. For analgesia and
sedation longer than 72 hours, epidural analgesia was used by
46% of all hospitals, and peripheral blocks were used by 11%.
Epidural analgesia was used by 43% of all hospitals during
ventilator weaning, and peripheral blocks were used by 7% of
all hospitals.
The use of the different agents and techniques is summarized
in Table 1.
Discussion
The most important result is the use of different agents accord-
ing to the expected length of analgesia and sedation. In the
American guidelines [18] for short-term sedation only propofol
is recommended, and for long-term sedation midazolam and
lorazepam are recommended. In our survey the most com-
monly used agent for sedation up to 24 hours and during
weaning from ventilation was propofol. Midazolam was used
mainly for sedation longer than 72 hours. Lorazepam was not
Figure 1
The most commonly used sedative agents for the different sedation  periods The most commonly used sedative agents for the different sedation 
periods. *Differences between midazolam and propofol in a phase (χ2 
test, P < 0.05). The values were tested with the χ2 test (P < 0.05) and 
multiple differences with the Bonferroni–Holm multiple test procedure. 
(Propofol: less than 24 hours versus 24–72 hours versus more than 72 
hours versus weaning, all P < 0.0001. Midazolam: less than 24 hours 
versus 24–72 hours versus more than 72 hours versus weaning, all P < 
0.0001.)
Figure 2
The most commonly used analgesic agents during the different seda- tion periods The most commonly used analgesic agents during the different seda-
tion periods. *Differences between fentanyl and sufentanil in a phase 
(χ2 test, P < 0.05). The values were tested with the χ2 test (P < 0.05) 
and multiple differences with the Bonferroni–Holm multiple test proce-
dure. (Fentanyl: less than 24 hours versus 24–72 hours versus more 
than 72 hours versus weaning, all P < 0.01. Sufentanil: less than 24 
hours versus 24–72 hours; less than 24 hours versus more than 72 
hours; 24–72 hours versus more than 72 hours and 24–72 hours ver-
sus weaning, all P = 0.01; less than 24 hours versus weaning, P = 
0.04; more than 72 hours versus weaning, P = 0.55.)
Figure 3
Epidural analgesia, piritramid and NSAIDs in the different phases of  analgesia and sedation Epidural analgesia, piritramid and NSAIDs in the different phases of 
analgesia and sedation. The values were tested with the χ2 test (P < 
0.05) and multiple differences with the Bonferroni–Holm multiple test 
procedure. NSAIDs, non-steroidal anti-inflammatory drugs. (Epidural: 
less than 24 hours versus more than 72 hours; less than 24 hours ver-
sus weaning; 24–72 hours versus more than 72 hours and 24–72 
hours versus weaning, all P < 0.01; less than 24 hours versus 24–72 
hours, P = 0.015; more than 72 hours versus weaning, P = 0.37. Piritr-
amid: less than 24 hours versus 24–72 hours versus more than 72 
hours versus weaning, all P < 0.01. NSAIDs: less than 24 hours versus 
24–72 hours, less than 24 hours versus more than 72 hours and less 
than 24 hours versus weaning, all P < 0.0001; 24–72 hours versus 
more than 72 hours, P = 0.14; 24–72 hours versus weaning, P = 0.67; 
more than 72 hours versus weaning, P = 0.087.)Available online http://ccforum.com/content/9/2/R117
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used by any department. This is due mainly to handling (2 mg
ampoule) and costs, because lorazepam is one of the more
expensive agents in Germany for sedation.
Whereas the American guidelines recommend fentanyl, hydro-
morphone and morphine for analgesia in all phases [18], in our
survey fentanyl and sufentanil were used most often for anal-
gesia for up to 24 hours, between 24 and 72 hours and for
weaning from ventilation. In addition, NSAIDs were used pref-
erentially in short-term sedation (less than 24 hours). For
longer than 72 hours, fentanyl was preferred for analgesia.
Whereas in the British survey [15] from the year 2000 alfen-
tanil was very often used, this opioid did not have a role in Ger-
man ICUs. In the Danish survey the preferred drugs for
analgesia were morphine (94%), fentanyl (76%) and sufentanil
(43%) [16]. Our survey shows that morphine did not have a
major role in analgesia and sedation in German ICUs. Specifi-
cally in Germany, piritramide is a frequently used agent for
postoperative analgesia. The reason may be that in Germany
some anesthesiologists claim to achieve a lower incidence of
nausea and vomiting with piritramid than with morphine [22].
Noticeable was the widespread use of central neuroaxial tech-
niques in analgesia for up to 24 hours. Brodner and col-
leagues [23] and Beattie and colleagues [24] showed that the
perioperative use of epidural analgesia leads to a shortened
length of stay in the ICU and also a decrease in cardiac events.
Clonidine as an adjuvant for sedation was used in our survey
in a high percentage in all phases, whereas haloperidol, which
is recommended in the American guidelines, was not a
selectable option in our questionnaire. Most often clonidine
was used in the phases longer than 72 hours and during
weaning from ventilation. A reasonable use (with regard to
time of ventilation and ICU stay) of this agent during weaning
was shown by Walz and colleagues [25]. Bohrer and col-
leagues showed [26] that with clonidine the requirements for
opioids and sedation may be reduced.
Ketamine (S) was preferred as an adjuvant in the phases of
sedation longer than 24 hours. There have been few studies
for long-term sedation with ketamine, as Ostermann and col-
leagues [11] showed in their review. One of the reasons for
the use of ketamine is the lower negative influence on bowel
motility than with opioids [27].
In our survey 43% of the hospitals stated that they had have
established an oral policy for analgesia and sedation. A proce-
dure in writing was used in 21%. In the survey by Murdoch and
colleagues [15] 43% of the British ICUs stated that they had
procedures in writing for analgesia and sedation, and 51%
had a defined oral policy. In addition, in the 1987 survey of
British ICUs by Bion and colleagues [28], 40% stated that
they had established a formal procedure. In other surveys it
was shown that with the use of standard operating procedures
a decrease in the durations of sedation and ventilation, and
with this a reduction of costs, is possible [29,30]. Mascia and
colleagues [31] showed that the use of written standard oper-
ating procedures decreases the duration of ventilation, the
length of stay in the ICU and the overall hospital stay.
A sedation scale for the monitoring of analgesia and sedation
was used by 31% of the hospitals questioned; 8% stated that
they used the Ramsay sedation scale [21] for monitoring seda-
tion. In the survey by Soliman and colleagues [17], 49% of the
German hospitals answered that they used the Ramsay seda-
tion scale [19]. In English hospitals in the survey by Murdoch
and colleagues [15], 60% were using a sedation scale. In the
survey of Danish ICUs [16] from the year 1996/1997, 16% of
the hospitals answered that they were using a sedation scale.
More recent studies showed that close monitoring with the
help of a scoring system can lead to a decrease in the length
of ICU stay and in the length of hospital stay [32].
Nearly all hospitals in our survey stated that they paid attention
to cost in their choice of medication. However, the survey
showed that there were no significant differences in the use of
medications between the hospitals that answered yes and
those that answered no. Murdoch and colleagues [15] came
to the same conclusion in their survey of English ICUs. More
expensive agents may be useful with regard to overall costs
because the length of stay in the ICU may be reduced, as was
Figure 4
The most commonly used adjunct techniques in the different phases of  analgesia and sedation The most commonly used adjunct techniques in the different phases of 
analgesia and sedation. The values were tested with the χ2 test (P < 
0.05) and multiple differences with the Bonferroni–Holm multiple test 
procedure. (Clonidine: less than 24 hours versus more than 72 hours, 
less than 24 hours versus weaning and 24–72 hours versus weaning, 
all P < 0.01; 24 hours versus 24–72 hours, P = 0.23; 24–72 hours 
versus more than 72 hours, P < 0.017; more than 72 hours versus 
weaning, P = 0.067. Ketamine (S): less than 24 hours versus 24–72 
hours, less than 24 hours versus more than 72 hours, 24–72 hours ver-
sus weaning and more than 72 hours versus weaning, all P < 0.0001; 
less than 24 hours versus weaning, P = 0.22; 24–72 hours versus 
more than 72 hours, P = 0.087.)Critical Care    April 2005  Vol 9 No 2    Martin et al.
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shown by Barrientos-Vega and colleagues [33] and Dahaba
and colleagues [34].
Questioned on whether the expected length of sedation had a
role in selecting the medication, 92% of the hospitals agreed.
The analysis showed that for short-term sedation agents were
also used that had a long context-sensitive half-time (fentanyl
45%, midazolam 40%) [35]. Nearly all ICUs tried to maintain a
day–night rhythm, although only few studies exist [36,37] that
have shown advantages of it for the patients. The Danish sur-
vey [16] yielded almost the same results.
In our survey the use of neuromuscular blocking agents had
almost disappeared, confirming the results of the European
[17], British [15] and Danish [16] surveys of the routine use of
neuromuscular blocking agents in intensive care medicine.
The incidence of withdrawal in long-term sedation is 60–80%
[38,39]. In our survey, values between 20% and 25% were
stated, which is explained by the fact that all patients, even
short-term patients, were included.
In our survey the return rate was 84%. Christensen and col-
leagues [16] in Denmark and Murdoch and colleagues [15] in
the UK achieved similar return rates (92.5% and 79%, respec-
tively). In a pan-European questionnaire about the practice of
analgesia and sedation by Soliman and colleagues [17] the
return rate was 20%.
One of the problems of this survey was the limitation to ICUs
run by the department of anesthesiology. We do not have data
on whether the patients were mainly postoperative and trauma
patients, or whether the ICUs also routinely took care of
patients from the department of internal medicine. Hack and
colleagues showed in their survey [40] that the most of the
interdisciplinary ICUs in general hospitals in Germany are run
by the department of anesthesiology [40].
Conclusion
In German anesthesiological ICUs the main short-acting agent
used for sedation was propofol, and the benzodiazepine mida-
zolam was used for long-term sedation. For analgesia the opi-
oids fentanyl and sufentanil were used. A very large proportion
of hospitals used epidural analgesia. In addition, clonidine was
very often used as an adjuvant agent. Only a small proportion
of hospitals had established a sedation protocol in writing or a
scoring system for the monitoring of analgesia and sedation,
although numerous publications showed that the consistent
use of these methods can lead to a decrease in ventilator time
and length of ICU stay [29-31].
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